Downregulation of miR-146a, cyclooxygenase-2 and advanced glycation end-products in simvastatin-treated older patients with hyperlipidemia

Geriatrics & Gerontology International
Zhou Xin YangHong Yu

Abstract

Hyperlipidemia is a disease with abnormally elevated levels of lipids/lipoproteins in the blood, and it is regarded as an important risk factor for cardiovascular and cerebrovascular diseases. Statins have been found to prevent vascular diseases by reducing low-density lipoprotein cholesterol and regulation of immune responses. Here, we aim to study the expression change of immune-related microRNA and genes in older patients with hyperlipidemia after treatment with simvastatin. A total of 25 older male patients with hyperlipidemia were included in the study and received simvastatin treatment (20 mg/day). Clinical characteristics of these patients were examined, including lipoprotein cholesterol, high-sensitivity C-reactive protein, blood routine and biochemical characters. We tested miR-146a, interleukin-1-receptor-associated kinase 1, tumor necrosis factor-receptor-associated factor 6 and cyclooxygenase-2 level by real-time polymerase chain reaction, and expressions of advanced glycation end-products, p53 and p21 were analyzed by enzyme-linked immunosorbent assay. Simvastatin treatment effectively reduced total cholesterol and low-density lipoprotein cholesterol, but had little effect on high-density lipoprotein cholesterol. H...Continue Reading

References

Sep 17, 1976·Science·R Ross, L Harker
Oct 16, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·S A HuberR Tracy
May 8, 2004·Mechanisms of Ageing and Development·Ji Hyun HanJin Ho Chung
Jan 25, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jeffrey R JacobsonJoe G N Garcia
Aug 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Konstantin D TaganovDavid Baltimore
Aug 22, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tamar AprahamianKenneth Walsh
Jul 7, 2007·Molecular Cell·Andrew GrimsonDavid P Bartel
Apr 9, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mark M PerryMark A Lindsay
May 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xin ZhangSilva Markovic-Plese
Dec 2, 2008·Cytokine & Growth Factor Reviews·James E McLaren, Dipak P Ramji
Jun 5, 2013·EMBO Molecular Medicine·Henry S ChengJason E Fish

❮ Previous
Next ❯

Citations

Jan 12, 2019·Physiological Genomics·Alisha R CoffeyBrian J Bennett
Nov 27, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M SidorkiewiczA Piekarska
Dec 14, 2018·Experimental and Therapeutic Medicine·Haiming DangHongjia Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.